# MSA-01 in Multiple System Atrophy

> **NCT07446894** · PHASE3 · RECRUITING · sponsor: **Tokyo University** · enrollment: 140 (estimated)

## Conditions studied

- Multiple System Atrophy (MSA)

## Interventions

- **DRUG:** MSA-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07446894
- **Lead sponsor:** Tokyo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07446894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07446894, "MSA-01 in Multiple System Atrophy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07446894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*